Literature DB >> 19876779

Does the sequence of taxane administration affect the outcome of patients with breast cancer in the adjuvant and neoadjuvant settings?

Ali Alkan, Ugur Sahin, Kadri Altundag.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 19876779     DOI： 10.1007/s12032-009-9322-9

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  2 in total

1.  Paclitaxel decreases the interstitial fluid pressure and improves oxygenation in breast cancers in patients treated with neoadjuvant chemotherapy: clinical implications.

Authors:  Alphonse G Taghian; Rita Abi-Raad; Sherif I Assaad; Adrian Casty; Marek Ancukiewicz; Eren Yeh; Peryhan Molokhia; Khaled Attia; Timothy Sullivan; Irene Kuter; Yves Boucher; Simon N Powell
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

2.  FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG).

Authors:  Aristides Polyzos; Nikolaos Malamos; Ioannis Boukovinas; Adamos Adamou; Nikolaos Ziras; Kostas Kalbakis; Stylianos Kakolyris; Kostas Syrigos; Pavlos Papakotoulas; Charalambos Kouroussis; Nikolaos Karvounis; Lambros Vamvakas; Charalambos Christophyllakis; Athanasios Athanasiadis; Ioannis Varthalitis; Vassilis Georgoulias; Dimitris Mavroudis
Journal:  Breast Cancer Res Treat       Date:  2009-07-28       Impact factor: 4.872
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.